BFS (ictu, sigilli) Solutions ad intravenous (IV) et ampoule products
Flare-sigillum-sigillum productio lineaTechnology technology technology adoptat specialized aseptic. Potest operari continue et succendam in P. vel PP granulis ad continens, tunc consummare implens et signantes statim et producere in quo velox et continua via. Coniungit plures vestibulum processus in una apparatus, quae potest consummare flante, saturitatem, sigillaing processus in unum opus statione sub aseptic conditio, ut certus in salutem in usum.
Potest esse late in terminatio sterilitate products et aseptic products ut magna volumine IV utres, parva volumine injectable ampoules aut oculus guttae etc. Hanc Fortuna, non particulas, non Pyrognology habet features of sterilitate, non particulas, nec Pyrognology, et commendatur a USA pharmacopopeia.


NO | Descriptio | Parameter |
1 | Deflash | Extra deflash |
2 | Power Source | 3P / AC, 380V / 50Hz |
3 | Machina structure | Nigrum et albus separata regio |
4 | Stipare materiae | PP / PE / Petr |
5 | Specificatio | 0.2-5ml, 5-20ml, 10-30ml, 50-1000ML |
6 | Facultas | 2400-18000bph |
7 | SPECTATIO | ± 1.5% ad pura aqua. (5ml) |
8 | Vexillum vestibulum | CGMP, Euro GMP |
9 | Electrical Latin | IEC 60204-1 Electrical Equipment pro Safety MachineryGB / T (IV) DCCXXVIII graphical symbola ad diagrams |
10 | Compressum aeris | Oleum et aquam libera, @ 8BAR |
11 | Refrigerandum aquae | XII ℃ pura aqua @ 4BAR |
16 | Vapor | CXXV ℃ @ 2BAR |
Exemplar | Cavatio | Facultatem (utrem per hora) | Specificatio |
BFS30 | 30 | (IX) | 0.2-5ml |
BFS20 | 20 | (VI) | 5-20ml |
BFS15 | 15 | (IV) | 10-30ml |
BFS8 | 8 | MDC | 50-500ml |
BFS6 | 6 | MCC | 50-1000ML |
BFSD30 | XXX duplex | (XVIII) | 0.2-5ml |
BFSD20 | Puer XX | (XII) | 5-20ml |
Bfsd15 | XV duplex | (IX) | 10-30ml |
BFSD8 | Duplex VIII | MMMCC | 50-500ml |
BFSD6 | Duplum VI | MMCD | 50-1000ML |